Sarcoma, Kaposi: Clinical Trials

9 trials for Sarcoma, Kaposi, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 not yet recruiting, 1 unknown. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 7, Not yet recruiting 1, Unknown 1

Follow Sarcoma, Kaposi: new trials by email Literature Review of Sarcoma, Kaposi trials Research Report on Sarcoma, Kaposi

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
Pegylated liposomal doxorubicin, Paclitaxel - Kaposi Sarcoma, HIV-1-infection
Phase 3Not yet recruitingAIDS Malignancy Consortium1302026-09-012026-01-23
Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
efavirenz/emtricitabine/tenofovir disoproxil fumarate, etoposide - HIV-1 Infection, Kaposi's Sarcoma
Phase 3CompletedAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1922011-11-182019-11-14
A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
Zidovudine - HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2402021-11-04
Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
Doxorubicin hydrochloride (liposomal) - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedSequus Pharmaceuticals2005-06-24
A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
Doxorubicin hydrochloride (liposomal), Bleomycin sulfate, Vincristine sulfate - Sarcoma, Kaposi, HIV Infections
Phase 3UnknownSequus Pharmaceuticals2252005-06-24
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
IM862 - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedCytran2002005-06-24
A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
Daunorubicin (liposomal), Bleomycin sulfate, Vincristine sulfate - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedNexstar Pharmaceuticals2005-06-24
Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
Doxorubicin hydrochloride (liposomal), Bleomycin sulfate, Vincristine sulfate - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedSequus Pharmaceuticals2202005-06-24
A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
Doxorubicin hydrochloride (liposomal) - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedSequus Pharmaceuticals2005-06-24

Narrower conditions

Acquired Immunodeficiency Syndrome (7)  ·  HIV Infections (7)  ·  AIDS-Related Opportunistic Infections (2)  ·  AIDS-related Kaposi sarcoma (1)

Broader conditions

DNA Virus Infections (9)  ·  Herpesviridae Infections (9)  ·  Infections (9)  ·  Neoplasms (9)  ·  Neoplasms by Histologic Type (9)  ·  Neoplasms, Connective and Soft Tissue (9)  ·  Neoplasms, Vascular Tissue (9)  ·  Sarcoma (9)  ·  Virus Diseases (9)  ·  Blood-Borne Infections (8)  ·  Communicable Diseases (8)  ·  Genital Diseases (8)  ·  Immune System Diseases (8)  ·  Immunologic Deficiency Syndromes (8)  ·  Lentivirus Infections (8)

Interventions

Doxorubicin (5)  ·  Liposomes (4)  ·  Bleomycin (3)  ·  Vincristine (3)  ·  Daunorubicin (1)  ·  Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Etoposide (1)  ·  Paclitaxel (1)  ·  Zidovudine (1)  ·  liposomal doxorubicin (1)

Sponsors

Sequus Pharmaceuticals (4)  ·  AIDS Malignancy Consortium (1)  ·  Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1)  ·  Cytran (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Nexstar Pharmaceuticals (1)

Countries

United States (7)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Peru (1)  ·  South Africa (1)  ·  Uganda (1)

Top investigators

Ariela Noy (1)  ·  David Scadden (1)  ·  Mina C Hosseinipour, M.D. (1)  ·  Parkash Gill (1)  ·  Susan Krown, MD (1)  ·  Thomas B Campbell, M.D. (1)  ·  Valentine FT (1)

Results publications

PMID 29365083, PMID 31520741, PMID 37368929, PMID 41286911

NIH funding

U01AI068636 (1), U01CA121947 (1)